Search

Your search keyword '"Barkati, Sapha"' showing total 40 results

Search Constraints

Start Over You searched for: Author "Barkati, Sapha" Remove constraint Author: "Barkati, Sapha" Database Unpaywall Remove constraint Database: Unpaywall
40 results on '"Barkati, Sapha"'

Search Results

2. Clinical Characteristics and Outcomes Among Travelers With Severe Dengue

3. Implementing a Patient Portal for the Remote Follow-up of Self-isolating Patients with COVID-19 Through Patient and Stakeholder Engagement: A Mixed-Method Pilot Study (the Opal-COVID Study) (Preprint)

5. Epidemiological and clinical characteristics of patients with monkeypox in the GeoSentinel Network: a cross-sectional study

6. Protection against omicron (B.1.1.529) BA.2 reinfection conferred by primary omicron BA.1 or pre-omicron SARS-CoV-2 infection among health-care workers with and without mRNA vaccination: a test-negative case-control study

7. Monkeypox in Montréal: Epidemiology, Phylogenomics, and Public Health Response to a Large North American Outbreak

8. Dengue outbreak among travellers returning from Cuba—GeoSentinel surveillance network, January–September 2022

9. Estimated Protection of Prior SARS-CoV-2 Infection Against Reinfection With the Omicron Variant Among Messenger RNA–Vaccinated and Nonvaccinated Individuals in Quebec, Canada

11. Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022

12. In-hospital outcomes of SARS-CoV-2-infected health care workers in the COVID-19 pandemic first wave, Quebec, Canada

15. Protection against Omicron BA.2 reinfection conferred by primary Omicron or pre-Omicron infection with and without mRNA vaccination

16. Protection against Omicron re-infection conferred by prior heterologous SARS-CoV-2 infection, with and without mRNA vaccination

17. Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, Canada

18. Outcomes of hospitalized COVID-19 patients in Canada: impact of ethnicity, migration status and country of birth

22. Two-dose SARS-CoV-2 vaccine effectiveness with mixed schedules and extended dosing intervals: test-negative design studies from British Columbia and Quebec, Canada

24. Single-Dose Messenger RNA Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 in Healthcare Workers Extending 16 Weeks Postvaccination: A Test-Negative Design From Québec, Canada

25. Single-dose mRNA vaccine effectiveness against SARS-CoV-2 in healthcare workers extending 16 weeks post-vaccination: a test-negative design from Quebec, Canada

Catalog

Books, media, physical & digital resources